Published in Clin Infect Dis on December 15, 2014
Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics (1999) 4.86
Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75
New intrauterine growth curves based on United States data. Pediatrics (2010) 3.72
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep (2013) 3.08
Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol (1990) 1.78
17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol (2012) 1.49
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine (2003) 1.48
Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine (2003) 1.31
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt. Vaccine (2012) 1.30
Apnea, sudden infant death syndrome, and home monitoring. Pediatrics (2003) 1.25
Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J (2013) 1.10
A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics (2011) 1.09
Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates. Antimicrob Agents Chemother (2009) 1.05
Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis (2013) 1.01
ACOG Committee Opinion No. 566: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol (2013) 0.92
The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Semin Perinatol (1997) 0.92
Research on vaccines during pregnancy: protocol design and assessment of safety. Vaccine (2013) 0.87
Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. Vaccine (2008) 0.86
Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments. Vaccine (2013) 0.86
Approach to the bleeding newborn. Paediatr Child Health (1998) 0.85
Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials. Clin Infect Dis (2014) 0.80
Preventing newborn infection with maternal immunization. Sci Transl Med (2013) 0.79